The Evolving Post-PCI Antithrombotic Therapies

Prolonged dual antiplatelet therapy is the treatment of choice for patients with an acute coronary syndrome who have undergone percutaneous coronary intervention (PCI) with a drug-eluting stent.1,2 The rationale is anchored in the understanding that drug-eluting stents impair the vascular healing process, because exposure of the metal in the stent serves as a nidus for stent thrombosis.2,3 The technology for drug-eluting stents has evolved from...